flurbiprofen has been researched along with 6-ketoprostaglandin f1 alpha in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antal, EJ; Buchanan, WW; Cauvier, H; Grace, EM; Kean, WF; Rischke, J | 1 |
| Bolling, SF; Deeb, GM; Grum, CM; Ljungman, AG; Morganroth, ML | 1 |
| Caen, J; Corvazier, E; Maclouf, J; Pintigny, D; Wautier, JL; Wautier, MP | 1 |
| Brown, CG; Poyser, NL | 1 |
| Barati, M; Butulija, D; Hamid, H; Kulkarni, PS | 1 |
| De la Cruz, JP; Gonzalez-Correa, JA; Jebrouni, N; Lopez-Villodres, JA; Reyes, JJ; Ruiz-Moreno, MI | 1 |
| Fujimoto, Y; Hirakawa, K; Hotta, A; Nakamoto, A; Nomura, Y; Ohira, N; Tatekawa, S; Yoshikawa, N | 1 |
| Arai, H; Arita, M; Iwamoto, R; Shida, D; Suzuki, T; Tagawa, K; Takahashi, H | 1 |
3 trial(s) available for flurbiprofen and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
The pharmacokinetics of flurbiprofen in younger and elderly patients with rheumatoid arthritis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Age Factors; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Body Weight; Female; Flurbiprofen; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Thromboxane B2 | 1992 |
Flurbiprofen axetil provides a prophylactic benefit against mesenteric traction syndrome associated with remifentanil infusion during laparotomy.
Topics: 6-Ketoprostaglandin F1 alpha; Abdomen; Aged; Anesthesia, General; Anesthetics, Intravenous; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Epoprostenol; Female; Flurbiprofen; Humans; Hypnotics and Sedatives; Hypotension; Infusions, Intravenous; Laparotomy; Male; Midazolam; Middle Aged; Piperidines; Postoperative Complications; Preanesthetic Medication; Prospective Studies; Remifentanil; Splanchnic Circulation | 2012 |
Therapeutic effects of flurbiprofen axetil on mesenteric traction syndrome: randomized clinical trial.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Colorectal Neoplasms; Epoprostenol; Female; Flurbiprofen; Flushing; Hemodynamics; Humans; Hypotension; Infusions, Intravenous; Intraoperative Complications; Laparotomy; Male; Middle Aged; Prospective Studies; Syndrome; Tachycardia | 2017 |
5 other study(ies) available for flurbiprofen and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Blood Pressure; Cyclooxygenase Inhibitors; Dinoprost; Flurbiprofen; Hydrogen Peroxide; Indomethacin; Lung; Male; Prostaglandin-Endoperoxide Synthases; Pulmonary Artery; Rats; Rats, Inbred Strains; Reperfusion Injury; Thromboxane B2; Thromboxane-A Synthase | 1991 |
Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Adenosine Triphosphate; Adult; Anemia, Sickle Cell; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Blood Proteins; Blood Vessels; Cell Adhesion; Cells, Cultured; Cyclooxygenase Inhibitors; Diabetes Mellitus; Endothelium; Epoprostenol; Erythrocytes; Fibrinogen; Flurbiprofen; Humans; Leukocytes; Middle Aged; Plasma; Prostaglandins F; Thromboxane B2 | 1986 |
Studies on the control of prostaglandin production by the hypothalamus in relation to LH release in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Castration; Circadian Rhythm; Dinoprost; Dinoprostone; Estradiol; Estrus; Female; Flurbiprofen; Hypothalamus; Luteinizing Hormone; Median Eminence; Norepinephrine; Pregnancy; Preoptic Area; Progesterone; Prostaglandins; Prostaglandins E; Prostaglandins F; Radioimmunoassay; Rats; Rats, Inbred Strains; Thromboxane B2 | 1984 |
Angiotensin II-induced constrictions are masked by bovine retinal vessels.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Cattle; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Flurbiprofen; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Retinal Vessels; Saralasin; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Differences in the in vitro antiplatelet effect of dexibuprofen, ibuprofen, and flurbiprofen in human blood.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Dinoprostone; Dose-Response Relationship, Drug; Female; Flurbiprofen; Humans; Ibuprofen; Leukocytes; Male; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2 | 2010 |